1-3 of 3
Chris Holland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term survival and T-cell kinetics in relapsed/refractory ALL patients who achieved MRD response after blinatumomab treatment

Clinical Trials & Observations
Gerhard Zugmaier, Nicola Gökbuget, Matthias Klinger, Andreas Viardot, Matthias Stelljes, Svenja Neumann, Heinz-A. Horst, Reinhard Marks, Christoph Faul, Helmut Diedrich, Albrecht Reichle, Monika Brüggemann, Chris Holland, Margit Schmidt, Hermann Einsele, Ralf C. Bargou, Max S. Topp
Journal: Blood
Blood (2015) 126 (24): 2578–2584.
https://doi.org/10.1182/blood-2015-06-649111
Published: 2015
Includes: Supplemental data
Journal Articles

Long-Term Survival in Adult Patients with Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Achieved Minimal Residual Disease (MRD) Response Following Anti-CD19 BiTE ® Blinatumomab

Gerhard Zugmaier, Nicola Goekbuget, Andreas Viardot, Matthias Stelljes, Svenja Neumann, Heinz A. Horst, Albrecht Reichle, Reinhard Marks, Christoph Faul, Monika Brueggemann, Chris Holland, Margit Schmidt, Noemi Mergen, Marie-Elisabeth Goebeler, Hermann Einsele, Ralf C. Bargou, Max S. Topp
Journal: Blood
Blood (2014) 124 (21): 2287.
https://doi.org/10.1182/blood.V124.21.2287.2287
Published: 2014
Journal Articles

A Phase 1/2 Study Of Blinatumomab In Pediatric Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Arend von Stackelberg, Gerhard Zugmaier, Rupert Handgretinger, Franco Locatelli, Carmelo Rizzari, Tanya M. Trippett, Arndt Borkhardt, MD, Susan R. Rheingold, Peter Bader, Deepa Bhojwani, MD, Todd Michael Cooper, Steven G. DuBois, Maureen M. O'Brien, MD, Christian M. Zwaan, Chris Holland, Noemi Mergen, Anja Fischer, Min Zhu, Youssef Hijazi, James Whitlock, Lia Gore, MD
Journal: Blood
Blood (2013) 122 (21): 70.
https://doi.org/10.1182/blood.V122.21.70.70
Published: 2013